BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han X, Bao X, Lou Q, Xie X, Zhang M, Zhou S, Guo H, Jiang G, Shi Q. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice. PeerJ 2019;7:e7568. [PMID: 31523515 DOI: 10.7717/peerj.7568] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Y, Chen D, Zhao Y, Zhu J, Dong X. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice. Int J Immunopathol Pharmacol 2021;35:20587384211036819. [PMID: 34399601 DOI: 10.1177/20587384211036819] [Reference Citation Analysis]
2 Yang Q, Cong L, Wang Y, Luo X, Li H, Wang H, Zhu J, Dai S, Jin H, Yao G, Shi S, Hsueh AJ, Sun Y. Increasing ovarian NAD+ levels improve mitochondrial functions and reverse ovarian aging. Free Radic Biol Med 2020;156:1-10. [PMID: 32492457 DOI: 10.1016/j.freeradbiomed.2020.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
3 Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther 2020;5:227. [PMID: 33028824 DOI: 10.1038/s41392-020-00311-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
4 Abdellatif M, Sedej S, Kroemer G. NAD+ Metabolism in Cardiac Health, Aging, and Disease. Circulation 2021;144:1795-817. [PMID: 34843394 DOI: 10.1161/CIRCULATIONAHA.121.056589] [Reference Citation Analysis]
5 Bogan-Brown K, Nkrumah-Elie Y, Ishtiaq Y, Redpath P, Shao A. Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19. J Diet Suppl 2021;:1-29. [PMID: 33594938 DOI: 10.1080/19390211.2021.1881686] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Quesada-Vázquez S, Colom-Pellicer M, Navarro-Masip È, Aragonès G, Del Bas JM, Caimari A, Escoté X. Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice. Nutrients 2021;13:3532. [PMID: 34684533 DOI: 10.3390/nu13103532] [Reference Citation Analysis]
7 Dabravolski SA, Bezsonov EE, Orekhov AN. The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression. Biomed Pharmacother 2021;142:112041. [PMID: 34411916 DOI: 10.1016/j.biopha.2021.112041] [Reference Citation Analysis]
8 Zhu Y, Ruan S, Shen H, Guan Q, Zhai L, Yang Y. Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB. Int Immunopharmacol 2021;101:108290. [PMID: 34717194 DOI: 10.1016/j.intimp.2021.108290] [Reference Citation Analysis]
9 Dall M, Hassing AS, Treebak JT. NAD+ and NAFLD - caution, causality and careful optimism. J Physiol 2021. [PMID: 33932956 DOI: 10.1113/JP280908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khaidizar FD, Bessho Y, Nakahata Y. Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process. Int J Mol Sci 2021;22:3709. [PMID: 33918226 DOI: 10.3390/ijms22073709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 de Castro JM, Assumpção JAF, Stein DJ, Toledo RS, da Silva LS, Caumo W, Carraro CC, da Rosa Araujo AS, Torres ILS. Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction. Life Sci 2020;263:118596. [PMID: 33080243 DOI: 10.1016/j.lfs.2020.118596] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]